Gaudium IVF IPO Details, Financials, Valuation & Peers
Explore Gaudium IVF IPO details, including IPO dates, financial statements, valuation, peer comparison and more.
Overview
Gaudium IVF and Women Health Limited, incorporated in March 2015, is a company providing In Vitro Fertilization (IVF) treatments and specialized fertility services across India.
Core Business: In Vitro Fertilization (IVF) treatments and related fertility services.
Main Products/Services: In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), ovulation induction, comprehensive gynaecological care for PCOD/PCOS and endometriosis, and high-risk pregnancy management.
Industry Focus: Assisted Reproductive Technology (ART) and Women's Health.
Key Highlights:
- Operates over thirty locations utilizing a hub-and-spoke model, with seven hubs and twenty-eight spokes.
- Engaged in a strategic alliance with Infertility Experts to raise awareness about ART and IVF.
- Serves international patients from countries including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
- Has established centers in major Indian cities such as Delhi, Mumbai, Ludhiana, Srinagar, Patna, and Bangalore.
- Offers specialized treatments addressing infertility challenges for both genders and provides comprehensive gynaecological and high-risk pregnancy care.
Objects of the Issue
- Funding capital expenditure towards establishment of New IVF Centers of the Company.
- Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company.
- General Corporate Purpose
- Total
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 20 Feb - 24 Feb 2026 |
| IPO Price Band | ₹75 - ₹79 per share |
| Fresh Issue | 90.00 Cr |
| Offer For Sale | 75.00 Cr |
| Total IPO Size | 165.00 Cr |
| Face Value | 5 |
| Listing On | BSE, NSE |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 20 Feb 2026 |
| IPO Closing Date | 24 Feb 2026 |
| Basis Of Allotment | 25 Feb 2026 |
| Refunds | 25 Feb 2026 |
| Demat Transfer | 26 Feb 2026 |
| IPO Listing Date | 27 Feb 2026 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 | 30 Sep 2025 |
|---|---|---|---|---|
| Assets | 36.63 | 51.01 | 88.51 | 106.62 |
| Total Income | 44.26 | 48.15 | 70.96 | 49.75 |
| Profit After Tax | 13.53 | 10.32 | 19.13 | 12.51 |
| EBITDA | 20.07 | 19.27 | 28.63 | 18.95 |
| NET Worth | 22.73 | 26.99 | 46.30 | 58.85 |
| Reserves and Surplus | 21.74 | 26.00 | 15.60 | 28.16 |
| Total Borrowing | 9.78 | 15.73 | 18.93 | 22.51 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Peer Comparison
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
| Name | P/E | EPS | RoNW | NAV |
|---|---|---|---|---|
| Gaudium IVF and Women Health | 25.32 | 3.12 | 41.71% | 7.54 |
| Inspire IVF Public Company | 11.43 | 0.17 | 3.97% | 4.34 |
| Progyny Inc. | 41.56 | 50.52 | 12.9% | 394.2 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
IPO Reservation
| Investor Type | Shares Offered |
|---|---|
| Qualified Institutional Buyer (QIB) | Not more than 50% of the Net Issue |
| Non-Institutional Investor (NII/HNI) | Not less than 15% of the Net Issue |
| Retail Individual Investor (RII) | Not less than 35% of the Net Issue |
Subscription Data from NSE and BSE
| Investor Type | Subscribed |
|---|---|
| Qualified Institutional Buyer (QIB) | 1.62 |
| Non-Institutional Investor (NII/HNI) | 14.05 |
| Retail Individual Investor (RII) | 7.6 |
| Total | 7.27 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
IPO Registrar
MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited)
Phone: + 91 810 811 4949
Email: ipo.helpdesk@linkintime.co.in
Website: https://linkintime.co.in/
Lead Managers
- Sarthi Capital Advisors Pvt.Ltd.
Company Address
Gaudium IVF & Women Health Ltd.
B1/51,
Janak Puri,
B-1,
New Delhi, New Delhi –110058
Website:https://www.gaudiumivfcentre.com/
Phone:011-4885 8585
Email:compliance@gaudiumivfcentre.com
FAQs
- What is the issue size of the Gaudium IVF IPO?The Gaudium IVF IPO has an issue size of 165.00 Cr. This includes a fresh issue of 90.00 Cr and an offer for sale (OFS) of 75.00 Cr.
- What is the price band of the Gaudium IVF IPO?The price band for the Gaudium IVF IPO is ₹75 - ₹79 per share.
- What are the bidding dates for the Gaudium IVF IPO?The Gaudium IVF IPO will open for bidding on 20 Feb 2026 and close on 24 Feb 2026.
- What is the allotment date for the Gaudium IVF IPO?The allotment date for the Gaudium IVF IPO is 25 Feb 2026.
- What is the minimum lot size and investment required for the Gaudium IVF IPO?The minimum lot size for the Gaudium IVF IPO is 189 shares and the minimum investment required is ₹14,931.
- What is the listing date for the Gaudium IVF IPO?The listing date for the Gaudium IVF IPO is 27 Feb 2026.
- What is the Gaudium IVF IPO grey market premium?The grey market premium (GMP) for the Gaudium IVF IPO is currently at ₹0, with an expected listing gain of approximately 0%. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.